Business Description
Founded in 2008 and based in Mainz, Germany, BioNTech SE is a biotechnology company best known for developing one of the first mRNA vaccines against COVID-19. Beyond infectious diseases, the company is building a broad pipeline of cancer treatments targeting a wide range of tumor types, including lung, breast, colorectal, and pancreatic cancers, with several candidates currently in late-stage clinical trials. BioNTech is also advancing vaccines for other infectious diseases such as tuberculosis, malaria, influenza, and mpox.
